These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 16806589

  • 1. Exploring QSAR on 3-aminopyrazoles as antitumor agents for their inhibitory activity of CDK2/cyclin A.
    Samanta S, Debnath B, Basu A, Gayen S, Srikanth K, Jha T.
    Eur J Med Chem; 2006 Oct; 41(10):1190-5. PubMed ID: 16806589
    [Abstract] [Full Text] [Related]

  • 2. 3D-QSAR CoMFA study on indenopyrazole derivatives as cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 2 (CDK2) inhibitors.
    Singh SK, Dessalew N, Bharatam PV.
    Eur J Med Chem; 2006 Nov; 41(11):1310-9. PubMed ID: 16890327
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 3-Amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: a new class of CDK2 inhibitors.
    Pevarello P, Fancelli D, Vulpetti A, Amici R, Villa M, Pittalà V, Vianello P, Cameron A, Ciomei M, Mercurio C, Bischoff JR, Roletto F, Varasi M, Brasca MG.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):1084-90. PubMed ID: 16290148
    [Abstract] [Full Text] [Related]

  • 5. Molecular modelling on small molecular CDK2 inhibitors: an integrated approach using a combination of molecular docking, 3D-QSAR and pharmacophore modelling.
    Yuan H, Liu H, Tai W, Wang F, Zhang Y, Yao S, Ran T, Lu S, Ke Z, Xiong X, Xu J, Chen Y, Lu T.
    SAR QSAR Environ Res; 2013 Oct 15; 24(10):795-817. PubMed ID: 23941641
    [Abstract] [Full Text] [Related]

  • 6. 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization.
    Pevarello P, Brasca MG, Orsini P, Traquandi G, Longo A, Nesi M, Orzi F, Piutti C, Sansonna P, Varasi M, Cameron A, Vulpetti A, Roletto F, Alzani R, Ciomei M, Albanese C, Pastori W, Marsiglio A, Pesenti E, Fiorentini F, Bischoff JR, Mercurio C.
    J Med Chem; 2005 Apr 21; 48(8):2944-56. PubMed ID: 15828833
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitors.
    Ibrahim DA, Ismail NS.
    Eur J Med Chem; 2011 Dec 21; 46(12):5825-32. PubMed ID: 22000924
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structure-based discovery and optimization of potential cancer therapeutics targeting the cell cycle.
    Thomas MP, McInnes C.
    IDrugs; 2006 Apr 21; 9(4):273-8. PubMed ID: 16596481
    [Abstract] [Full Text] [Related]

  • 10. 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: an insight into the criteria for selectivity.
    Dessalew N, Bharatam PV.
    Eur J Med Chem; 2007 Jul 21; 42(7):1014-27. PubMed ID: 17335939
    [Abstract] [Full Text] [Related]

  • 11. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.
    Li Y, Gao W, Li F, Wang J, Zhang J, Yang Y, Zhang S, Yang L.
    Mol Biosyst; 2013 Sep 21; 9(9):2266-81. PubMed ID: 23864105
    [Abstract] [Full Text] [Related]

  • 12. Possible anticancer agents: QSAR analogs of glutamamide: synthesis and pharmacological activity of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides.
    Samanta S, Alam SM, Panda P, Jha T.
    Eur J Med Chem; 2009 Jan 21; 44(1):70-82. PubMed ID: 18456372
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.